Kiniksa Pharmaceuticals International Plc. Overview
Kiniksa Pharmaceuticals International Plc. Discounted Cash Flow
DCF Analysis for KNSA.
Get informed when a big investor buys or sells
+ FollowFair Value
$-4.53
Current Fair Value
$-4.53
↓ 108.7% Downside
Overvalued by 108.7% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison